Current partner codePEPTIDESDE
Evidence dashboardStudies since 2003Updated Jul 31, 2026

VasopressinClinical Trials.

A source-linked view of every Vasopressin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials
75
Recruiting
31
Completed
23
Terminated
1
Results posted
5
Average enrollment
295
Countries
19
Highest phase
Phase 4

Developer / research origin

Multiple

Evidence summary

Activity is not efficacy.

Vasopressin appears in 75 indexed studies: 31 recruiting, 23 completed and 5 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Vasopressin is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

20032026

Velocity

Vasopressin studies by start year

Study start year · indexed snapshot

2217116020032003: 2 trials2004: 1 trials2005: 0 trials2006: 0 trials20072007: 0 trials2008: 0 trials2009: 0 trials2010: 0 trials20112011: 0 trials2012: 0 trials2013: 0 trials2014: 1 trials20152015: 0 trials2016: 1 trials2017: 2 trials2018: 3 trials20192019: 1 trials2020: 0 trials2021: 2 trials2022: 3 trials20232023: 6 trials2024: 22 trials2025: 18 trials20262026: 13 trials

Development

Trials by phase

Early Phase 13
Phase 14
Phase 213
Phase 316
Phase 412

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

Showing 6 of 51 studies
Showing 6 of 23 studies

Full study index

Search Vasopressin trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

75 matching studies

Latest publications

Follow the paper trail.

PMID 26683499Allen RH, Goldberg AB. Cervical dilation before first-trimester surgical abortion (<14 weeks' gestation). Contraception. 2016 Apr;93(4):277-291. doi: 10.1016/j.contraception.2015.12.001. Epub 2015 Dec 9.Linked from NCT06502158PMID 20166091Kapp N, Lohr PA, Ngo TD, Hayes JL. Cervical preparation for first trimester surgical abortion. Cochrane Database Syst Rev. 2010 Feb 17;2010(2):CD007207. doi: 10.1002/14651858.CD007207.pub2.Linked from NCT06502158PMID 24331860Fox MC, Krajewski CM. Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4. Contraception. 2014 Feb;89(2):75-84. doi: 10.1016/j.contraception.2013.11.001. Epub 2013 Nov 11.Linked from NCT06502158PMID 11035353Ashok PW, Flett GM, Templeton A. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. Am J Obstet Gynecol. 2000 Oct;183(4):998-1002. doi: 10.1067/mob.2000.106767.Linked from NCT06502158PMID 22682721Borgatta L, Roncari D, Sonalkar S, Mark A, Hou MY, Finneseth M, Vragovic O. Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. Contraception. 2012 Nov;86(5):567-71. doi: 10.1016/j.contraception.2012.05.002. Epub 2012 Jun 6.Linked from NCT06502158PMID 27132200Ohannessian A, Baumstarck K, Maruani J, Cohen-Solal E, Auquier P, Agostini A. Mifepristone and misoprostol for cervical ripening in surgical abortion between 12 and 14 weeks of gestation: a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:151-5. doi: 10.1016/j.ejogrb.2016.04.007. Epub 2016 Apr 11.Linked from NCT06502158PMID 32007418Diedrich JT, Drey EA, Newmann SJ. Society of Family Planning clinical recommendations: Cervical preparation for dilation and evacuation at 20-24 weeks' gestation. Contraception. 2020 May;101(5):286-292. doi: 10.1016/j.contraception.2020.01.002. Epub 2020 Jan 31.Linked from NCT06502158PMID 36404279Jones RK, Kirstein M, Philbin J. Abortion incidence and service availability in the United States, 2020. Perspect Sex Reprod Health. 2022 Dec;54(4):128-141. doi: 10.1363/psrh.12215. Epub 2022 Nov 20.Linked from NCT06502158

Related pages

Keep researching Vasopressin.

Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.